Post-renovation BioPort ProductionFDA Lot-Release
AuthorizationsThese memos show the authority for the manufacturer to
release anthrax vaccine from the manufacturing plant. Each lot of every vaccine
produced in the United States must be individually released in this way, after
having been tested for sterility, purity, potency, and general safety.
Lot-release tests are performed by the manufacturer and audited by FDA.